Avanos Medical (AVNS) to Release Earnings on Wednesday

Avanos Medical (NYSE:AVNS - Get Free Report) will release its earnings data before the market opens on Wednesday, October 30th. Analysts expect Avanos Medical to post earnings of $0.36 per share for the quarter. Avanos Medical has set its FY24 guidance at $1.30-1.45 EPS and its FY 2024 guidance at 1.300-1.450 EPS.Investors that wish to register for the company's conference call can do so using this link.

Avanos Medical (NYSE:AVNS - Get Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.05. The business had revenue of $171.70 million for the quarter, compared to analyst estimates of $170.67 million. Avanos Medical had a net margin of 1.13% and a return on equity of 4.48%. The firm's revenue for the quarter was up 1.4% on a year-over-year basis. During the same quarter last year, the business posted $0.24 EPS. On average, analysts expect Avanos Medical to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Avanos Medical Price Performance

NYSE:AVNS traded down $0.15 during trading hours on Thursday, hitting $22.22. The company's stock had a trading volume of 151,362 shares, compared to its average volume of 236,985. Avanos Medical has a twelve month low of $17.24 and a twelve month high of $25.36. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.28 and a quick ratio of 1.49. The stock has a fifty day simple moving average of $23.48 and a 200-day simple moving average of $21.42. The company has a market capitalization of $1.02 billion, a P/E ratio of -16.80 and a beta of 0.91.

Analysts Set New Price Targets

Separately, StockNews.com raised shares of Avanos Medical from a "buy" rating to a "strong-buy" rating in a report on Tuesday, October 15th.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.